Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 3/20 | 0.59 |
| ▸ | TSHR | P16473 | 2/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.41 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.41 |
| ▸ | IDO1 | P14902 | 2/20 | 0.40 |
| ▸ | PAM | P19021 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29242053 | 0.90 | ALDH1A1 (0.46) | HTR2ATSHRALDH1A1GRIK1GRIK2 | |
| SCHEMBL2170349 | 0.90 | HTR2A (0.70) | HTR2AGRIK1GRIK2IDO1PAM | |
| SCHEMBL107852 | 0.90 | HTR2A (0.70) | HTR2AGRIK1GRIK2IDO1PAM | |
| SCHEMBL107851 | 0.90 | HTR2A (0.70) | HTR2AGRIK1GRIK2IDO1PAM | |
| Styrene SCHEMBL16875726 | 0.84 | ALDH1A1 (0.50) | HTR2ATSHRALDH1A1MEN1KMT2A | |
| Styrene SCHEMBL7201521 | 0.82 | ALDH1A1 (0.58) | HTR2ATSHRALDH1A1MEN1KMT2A | |
| Styrene SCHEMBL6325495 | 0.80 | ALDH1A1 (0.45) | HTR2ATSHRALDH1A1 | |
| SCHEMBL6435302 | 0.79 | HTR2A (0.61) | HTR2ATSHRALDH1A1GRIK1GRIK2 | |
| SCHEMBL6435300 | 0.79 | HTR2A (0.61) | HTR2ATSHRALDH1A1GRIK1GRIK2 | |
| SCHEMBL8826291 | 0.79 | HTR2A (0.66) | HTR2AGRIK1GRIK2IDO1PAM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 71 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7661541-B2 | Non-woven polymeric matrix for separation of leukocytes; continuous filament non-woven polymers made from biocompatible polymers | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2010-02-16 | — | — | US | claimed |
| US-20060261005-A1 | Non-woven polymeric matrix for separation of leukocytes; continuous filament non-woven polymers made from biocompatible polymers | DAO KINH-LUAN LENNY D | 2006-11-23 | — | — | US | claimed |
| US-7083697-B2 | Non-woven polymeric matrix for separation of leukocytes | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2006-08-01 | — | — | US | claimed |
| EP-1581273-A1 | ENGINEERED SCAFFOLDS FOR PROMOTING GROWTH OF CELLS | Boston Scientific Limited, an Irish company (BB) | 2005-10-05 | — | — | EP | claimed |
| EP-1578590-A2 | POROUS MELT SPUN POLYMERIC STRUCTURES AND METHOD OF MAKING THE SAME | SciMed Life Systems, Inc. (US) | 2005-09-28 | — | — | EP | claimed |
| WO-2004061177-A2 | POROUS SPUN POLYMERIC STRUCTURES AND METHOD OF MAKING SAME | SCIMED LIFE SYSTEMS, INC. (US) | 2004-07-22 | — | — | WO | claimed |
| WO-2004060426-A1 | ENGINEERED SCAFFOLDS FOR PROMOTING GROWTH OF CELLS | BOSTON SCIENTIFIC LIMITED (BB) | 2004-07-22 | — | — | WO | claimed |
| US-20040124146-A1 | Non-woven polymeric matrix for separation of leukocytes | SCIMED LIFE SYSTEMS, INC. | 2004-07-01 | — | — | US | claimed |
| US-20040126405-A1 | Engineered scaffolds for promoting growth of cells | SCIMED LIFE SYSTEMS, INC. | 2004-07-01 | — | — | US | claimed |
| CN-113893085-B | Systems and methods for delivering multiple ocular implants | 格劳科斯公司 | 2024-05-24 | — | — | CN | disclosed |
| US-11944573-B2 | System and method for delivering multiple ocular implants | GLAUKOS CORPORATION (US) | 2024-04-02 | — | — | US | disclosed |
| US-11618874-B2 | Methods for modulating osteochondral development using bioelectrical stimulation | MEDRELIEF INC. (US) | 2023-04-04 | — | — | US | disclosed |
| CN-113893085-A | Systems and methods for delivering multiple ocular implants | 格劳科斯公司 | 2022-01-07 | — | — | CN | disclosed |
| CN-110573117-B | Systems and methods for delivering multiple ocular implants | 格劳科斯公司 | 2021-10-26 | — | — | CN | disclosed |
| EP-1578590-A2 | POROUS MELT SPUN POLYMERIC STRUCTURES AND METHOD OF MAKING THE SAME | SciMed Life Systems, Inc. (US) | 2005-09-28 | — | — | EP | disclosed |
| US-20050208093-A1 | Phosphoryl choline coating compositions | ABBOTT CARDIOVASCULAR SYSTEMS INC. | 2005-09-22 | — | — | US | disclosed |
| WO-2004061177-A2 | POROUS SPUN POLYMERIC STRUCTURES AND METHOD OF MAKING SAME | SCIMED LIFE SYSTEMS, INC. (US) | 2004-07-22 | — | — | WO | disclosed |
| WO-2004060426-A1 | ENGINEERED SCAFFOLDS FOR PROMOTING GROWTH OF CELLS | BOSTON SCIENTIFIC LIMITED (BB) | 2004-07-22 | — | — | WO | disclosed |
| US-20040124146-A1 | Non-woven polymeric matrix for separation of leukocytes | SCIMED LIFE SYSTEMS, INC. | 2004-07-01 | — | — | US | disclosed |
| US-20040126405-A1 | Engineered scaffolds for promoting growth of cells | SCIMED LIFE SYSTEMS, INC. | 2004-07-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050208093-A1 | Phosphoryl choline coating compositions | PHOSPHO1, CHKA, SGMS1 | HTR2A 1900/4885TSHR 3910/4885ALDH1A1 4693/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.